Degludec (rDNA origin) 100IU/ml, 3ml { TRESIBA 3ML FLEXITOUCH PEN}
STORES/WEST CENTRAL RLY · Pharmaceuticals · open
Key facts
- Published: 03 Aug 2026
- Closing date: 09 Sep 2026
- Status: open
Description
Supply of Degludec (rDNA origin) 100IU/ml, 3ml TRESIBA FLEXITOUCH PEN to various WCR locations including Katni, Kota, and Jabalpur within 45 days, with no tender cost or EMD required. The tender is limited, open to approved sources, and evaluated itemwise.
Eligibility & requirements
- Startup relaxation: No
- MSE relaxation: No
New to these terms? Read how tender eligibility criteria work.
Commercial terms
- Bid type: Single Packet
- Evaluation: Itemwise/Consigneewise
- Make in India (MII): No
- MSE preference: No
Line items (3)
- Degludec (rDNA origin) 100IU/ml, 3ml TRESIBA FLEXITOUCH PEN — Qty: 15 Numbers
- Degludec (rDNA origin) 100IU/ml, 3ml TRESIBA FLEXITOUCH PEN — Qty: 75 Numbers
- Degludec (rDNA origin) 100IU/ml, 3ml TRESIBA FLEXITOUCH PEN — Qty: 50 Numbers
1 tender document(s) available — sign up to download.
Related tenders
- Torsemide 10 mg — Pharmaceuticals
- Bilastine 20 mg — Pharmaceuticals
- Paclitaxel 260 mg Injection — Pharmaceuticals · Madhya Pradesh
- TAB/CAP TEMOZOLAMIDE 100 MG. — Pharmaceuticals · Madhya Pradesh · ₹8.0L
- Megesterol 160 mg TABLETS — Pharmaceuticals · ₹10.0L
- Running Contract for Tab/Cap Azelnidipine 16 mg in strip packing. — Pharmaceuticals
- Running Contract for Sodium Chloride 3%, 100 ml Glass Bottle. — Pharmaceuticals
- Running Contract for Salbutamol 2.5 mg /2.5 ml Nebulising Solution 2.5 ml Respule/Amp. — Pharmaceuticals